Clinical characteristics and laboratory findings in 24 patients diagnosed with COVID-19.
| Variable | Results |
|---|---|
| Age (yr)a) | 55.5 (25–90) |
| Male sex (N, %) | 9/24 (38%) |
| Combined disease | |
| Hypertension | 3/24 (13%) |
| Diabetes | 4/24 (17%) |
| Chronic renal failure | 1/24 (4%) |
| N of days until molecular negative conversionb) | 30 (16–40) |
| Laboratory findings on admission dayc) | |
| Hemoglobin (g/dL) | 13.1 (10.1–16.1) |
| White blood cells (×103/µL) | 4.30 (2.24–7.44) |
| Neutrophils (×103/µL) | 2.50 (1.11–5.87) |
| Lymphocytes (×103/µL) | 1.15 (0.49–1.83) |
| Platelets (×103/µL) | 206 (107–554) |
| Prothrombin time (INR) | 1.0 (0.92–1.2) |
| Activated partial thromboplastin time (s) | 29.1 (21.7–34.2) |
| Peak fibrinogen (mg/dL) during hospitalization | 482.4 (230.4–863.2) |
| Peak D-dimer (ng/mL) during hospitalization | 0.5 (0.2–27.1) |
| Peak CRP (mg/dL) during hospitalization | 2.9 (0.1–17.8) |
| Outcome: survival | 24/24 (100%) |
a)Continuous value represent the median (min–max). b)Ten of the 24 patients were discharged after the asymptomatic period lasted more than 10 days before the molecular negative conversion. c)Complete blood count, prothrombin time, and activated partial thromboplastic time results were described for 20 of the 24 patients. The levels of fibrinogen, D-dimer, and CRP were described in 14, 16, and 22 out of 24 patients, respectively.
Blood Res 2021;56:56~58 https://doi.org/10.5045/br.2021.2020210
© Blood Research
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd